The inherent convenience and accessibility offered by smartphone photography further solidifies its status as a valuable tool in modern dermatologic practice. By adhering to the best practices outlined in this guide, dermatologists can utilize smartphones to capture high-quality clinical and dermoscopic images that aid in accurate diagnosis and enhance patient care.
Hidradenitis suppurativa (HS) is a debilitating dermatologic disorder characterized by recurrent inflammation that affects the apocrine glands and hair follicles and profoundly impacts patients' quality of life. Current treatment strategies ranging from topical therapies to systemic biologics aim to alleviate symptoms and prevent disease progression. Bimekizumab, an IL-17A and IL-17F inhibitor, has emerged as a promising intervention in the HS treatment landscape. We present a comprehensive review of the underlying molecular pathophysiology of HS, current standards of care, and evaluation of the efficacy and safety of bimekizumab.
Type 2 diabetes mellitus (T2DM) is a chronic disease with a rising prevalence worldwide that is characterized by hyperglycemia and insulin resistance. Metformin, which improves blood glucose levels and insulin sensitivity, is considered the first-line therapy for T2DM. In patients with T2DM who are overweight or obese, glucagonlike peptide 1 (GLP-1) and dual GLP-1/gastric inhibitory peptide (GIP) agonists are used as adjunct or alternative therapies given their dual benefits for insulin sensitivity and weight loss. Beyond the metabolic implications of T2DM medications, these agents also have hormonal and immunologic effects that may impact dermatologic diseases (eg, psoriasis, hidradenitis suppurativa [HS]). In this review, we highlight the dermatologic adverse effects and potential therapeutic benefits of metformin as well as GLP-1 and GLP-1/GIP agonists.
Seborrheic dermatitis (SD) is a common diagnosis in Black patients who seek care from a dermatologist; therefore it is important to have effective treatment approaches for SD in this patient population. In this study, we aimed to evaluate treatment options for SD in Black patients identified on consumer websites and in the medical literature. PubMed and Google searches were conducted to identify medical and nonmedical products and ingredients that commonly are used by Black patients to manage symptoms of SD. Our results indicated that there are many nuances to consider when treating Black patients with SD to prevent health disparities and provide culturally sensitive care.
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：